DE3033545A1 - Verwendung bekannter antiallergener mittel bei der bekaempfung von pathologischen mineralresorptionszustaenden - Google Patents

Verwendung bekannter antiallergener mittel bei der bekaempfung von pathologischen mineralresorptionszustaenden

Info

Publication number
DE3033545A1
DE3033545A1 DE19803033545 DE3033545A DE3033545A1 DE 3033545 A1 DE3033545 A1 DE 3033545A1 DE 19803033545 DE19803033545 DE 19803033545 DE 3033545 A DE3033545 A DE 3033545A DE 3033545 A1 DE3033545 A1 DE 3033545A1
Authority
DE
Germany
Prior art keywords
conditions
pathological
resorption
pathological mineral
states
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19803033545
Other languages
German (de)
English (en)
Inventor
John Edward Framingham Mass. Horton
William Julius Kalamazoo Mich. Wechter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of DE3033545A1 publication Critical patent/DE3033545A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Cosmetics (AREA)
DE19803033545 1979-09-07 1980-09-05 Verwendung bekannter antiallergener mittel bei der bekaempfung von pathologischen mineralresorptionszustaenden Withdrawn DE3033545A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7340079A 1979-09-07 1979-09-07
US7339879A 1979-09-07 1979-09-07

Publications (1)

Publication Number Publication Date
DE3033545A1 true DE3033545A1 (de) 1981-04-02

Family

ID=26754428

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19803033545 Withdrawn DE3033545A1 (de) 1979-09-07 1980-09-05 Verwendung bekannter antiallergener mittel bei der bekaempfung von pathologischen mineralresorptionszustaenden

Country Status (8)

Country Link
JP (1) JPS5649317A (it)
AU (1) AU532512B2 (it)
BE (1) BE885113A (it)
DE (1) DE3033545A1 (it)
FR (1) FR2464716B1 (it)
GB (1) GB2058564B (it)
IT (1) IT1174303B (it)
NL (1) NL8004904A (it)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4764334A (en) * 1983-10-17 1988-08-16 Westinghouse Electric Corp. Visual inspection system for radioactive fuel assemblies using fiberoptics
US4997824A (en) * 1987-07-22 1991-03-05 Teva Pharmaceutical Industries Ltd. Combination of cholecalciferol derivatives for the treatment of renal bone disease
US4911931A (en) * 1987-08-03 1990-03-27 Baylink David J Pharmaceutical combination for treatment of bone-wasting diseases
US5013728A (en) * 1990-05-04 1991-05-07 Colgate - Palmolive Company Composition for treating osteoporosis and hormonal imbalance
US6037339A (en) 1993-02-08 2000-03-14 Akzo Nobel N.V. C-11 substituted steroids for treating menopausal complaints
ZA94715B (en) * 1993-02-08 1994-10-24 Akzo Nv Steroids for treating menopausal complaints
US5710144A (en) * 1993-02-08 1998-01-20 Akzo Nobel N.V. C-11 substituted steroids for treating menopausal complaints
JP2001510450A (ja) * 1996-10-23 2001-07-31 ザイモジェネティクス，インコーポレイテッド 骨欠損状態を処置するための組成物および方法
DE19832169A1 (de) * 1998-07-17 2000-01-27 Jenapharm Gmbh Lokal anwendbare pharmazeutische Präparate zur Prophylaxe und Therapie atrophischer Erscheinungen in der Mundhöhle
EP1162890B1 (en) 1998-10-30 2005-10-12 RJ Innovation A method of preventing parturient hypocalcemia in animals and compositions used therein
WO2000067708A2 (en) * 1999-05-07 2000-11-16 Board Of Regents, The University Of Texas System Oral steroidal hormone compositions and methods of use
MXPA05014091A (es) * 2005-12-20 2007-06-20 Leopoldo De Jesus Espinosa Abdala Composiciones farmaceuticas que comprenden derivados de esteroides sinteticos, minerales y el metabolito activo de la vitamina d, 1,25(oh)2d3 (calcitriol) para la prevencion y tratamiento de la osteoporosis y el control de los sintomas de la menopaus
CN111602630A (zh) * 2020-06-24 2020-09-01 山西农业大学 呕吐毒素致肉鸡小肠机械性损伤模型的建立方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1473318A (en) * 1973-05-25 1977-05-11 Fisons Ltd Solution of 1,3-bis-2-carboxychromon-5-yloxy-propan-2-ol or salts thereof
US4029761A (en) * 1974-10-19 1977-06-14 Fisons Limited Method for treating gingivitis
IE41922B1 (en) * 1974-11-09 1980-04-23 Fisons Ltd Pharmaceutical compositions containing bis-chromones

Also Published As

Publication number Publication date
AU532512B2 (en) 1983-10-06
FR2464716B1 (fr) 1985-10-25
IT8049625A0 (it) 1980-09-05
FR2464716A1 (fr) 1981-03-20
JPS5649317A (en) 1981-05-02
AU6184380A (en) 1981-03-12
IT1174303B (it) 1987-07-01
BE885113A (fr) 1981-03-05
NL8004904A (nl) 1981-03-10
GB2058564B (en) 1983-10-26
GB2058564A (en) 1981-04-15

Similar Documents

Publication Publication Date Title
DE60113537T2 (de) Methode zur verabreichung von biphosphonaten
DE69629184T2 (de) Verwendung von vitamin d2 oder vitamin d4-derivaten zur herstellung eines medikamentes zur behandlung des sekundären hyperparathyroidismus
DE3686343T2 (de) Pharmazeutische zubereitung zur anwendung fuer die anreicherung von knochenmasse.
DE69822665T2 (de) Verwendung von 9-desoxy-2',9-alpha-methano-3-oxa-4,5,6-trinor-3,7-(1',3'-interphenylen)-13,14-dihydroprostaglandin-f1 zur behandlung von peripheren vaskulären erkrankungen
DE69016768T2 (de) Zusammensetzung und Verfahren für die Behandlung von Osteoporose bei Säugetieren.
DE69404675T2 (de) Pharmazeutische zusammensetzung zur intranasalen verabreichung von hydroxocobalamin
DE69201725T2 (de) Behandlungsmethoden für osteoporose.
DE69113386T2 (de) Herstellung von Medikamenten zur Behandlung von Asthma, unter Verwendung von (S)-Alpha-Fluoromethyl-Histidin und dessen Estern.
DE3428729A1 (de) Mittel zur verhinderung oder inhibierung einer alveolaeren knochenresorption
DE69826132T2 (de) Pharmazeutisches kombinationspräparat aus parathormon und einem inhibitor der knochenresorption
DE3033545A1 (de) Verwendung bekannter antiallergener mittel bei der bekaempfung von pathologischen mineralresorptionszustaenden
DE3519361A1 (de) (gamma)-ifn als wirkstoff zur hemmung (verhinderung) von abbauprozessen im knochen
EP0185210B1 (de) Verwendung von Dipeptidderivaten für die Herstellung von Arzneimitteln zur Behandlung von an amyotropher Lateralsklerose Erkrankten
DE60218842T2 (de) Orale verabreichung von parathyroidhormon und calcitonin
DE3201865C2 (de) Verwendung von 6-Amino-1-hydroxyhexan-1,1- diphosphonsäure und Derivaten davon zur Behandlung der Osteopathie
EP0236390B1 (de) Mittel gegen multiple sklerose
DE69200757T2 (de) Pharmazeutische Zusammensetzung zur Inhibierung der Knochenresorption.
DE69023939T2 (de) Förderung der Osteogenese durch Verwendung von Vitamin D-Derivaten.
DE69301750T2 (de) Verwendung von 1-Alpha,24(R)-Dihydroxy-22(E)-Dehydrovitamin-D3 zur Herstellung eines Arzneimittels zur Behandlung der Osteoporose
DE68919673T2 (de) Verfahren zur behandlung und vorbeugung des verlustes von knochenmasse.
DE60212710T2 (de) Pharmazeutische zubereitungen enthaltend epothilone und deren verwendung bei der behandlung von karzinoid
DE69125204T2 (de) Therapeutische Anwendung von Histamin-H3-Agonisten, neue Wirkstoffe und Verwendung zur Herstellung von Arzneimitteln
DE2366498C2 (it)
US4501754A (en) Methods of treating bone resorption
DE2401450A1 (de) Pharmazeutische zusammensetzung zur linderung von hautproliferationserkrankungen

Legal Events

Date Code Title Description
8128 New person/name/address of the agent

Representative=s name: HENKEL, G., DR.PHIL. FEILER, L., DR.RER.NAT. HAENZ

8141 Disposal/no request for examination